1Isolauri, E, Salminen, S & Ouwehand, AC (2004) Probiotics. Best Pract Res Clin Gastroenterol 18, 299–313.
2Sleator, RD & Hill, C (2008) New frontiers in probiotic research. Lett Appl Microbiol 46, 143–147.
3Paineau, D, Carcano, D, Leyer, G, et al. (2008) Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized, controlled trial. FEMS Immunol Med Microbiol 53, 107–113.
4Cross, ML, Ganner, A, Teilab, D, et al. (2004) Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria. FEMS Immunol Med Microbiol 42, 173–180.
5Ghadimi, D, Folster-Holst, R, de Vrese, M, et al. (2008) Effects of probiotic bacteria and their genomic DNA on T(H)1/T(H)2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology 213, 677–692.
6Helwig, U, Lammers, KM, Rizzello, F, et al. (2006) Lactobacilli, bifidobacteria and E. coli Nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. World J Gastroenterol 12, 5978–5986.
7Medina, M, Izquierdo, E, Ennahar, S, et al. (2007) Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications. Clin Exp Immunol 150, 531–538.
8Shida, K, Suzuki, T, Kiyoshima-Shibata, J, et al. (2006) Essential roles of monocytes in stimulating human peripheral blood mononuclear cells with Lactobacillus casei to produce cytokines and augment natural killer cell activity. Clin Vaccine Immunol 13, 997–1003.
9Haller, D, Blum, S, Bode, C, et al. (2000) Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets. Infect Immun 68, 752–759.
10Fink, LN, Zeuthen, LH, Christensen, HR, et al. (2007) Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses. Int Immunol 19, 1319–1327.
11Castellazzi, AM, Valsecchi, C, Montagna, L, et al. (2007) In vitro activation of mononuclear cells by two probiotics: Lactobacillus paracasei I 1688, Lactobacillus salivarius I 1794, and their mixture (PSMIX). Immunol Invest 36, 413–421.
12Takeda, K & Okumura, K (2007) Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity. J Nutr 137, 791S–793S.
13Albers, R, Antoine, JM, Bourdet-Sicard, R, et al. (2005) Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr 94, 452–481.
14Kankaanpaa, P, Sutas, Y, Salminen, S, et al. (2003) Homogenates derived from probiotic bacteria provide down-regulatory signals for peripheral blood mononuclear cells. Food Chem 83, 269–277.
15Zeuthen, LH, Christensen, HR & Frokiaer, H (2006) Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram-negative bacteria. Clin Vaccine Immunol 13, 365–375.
16Salminen, S, Collado, MC, Isolauri, E, et al. (2009) Microbial–host interactions: selecting the right probiotics and prebiotics for infants. Nestle Nutr Workshop Ser Pediatr Program 64, 201–217.
17Lopez, P, Gueimonde, M, Margolles, A, et al. (2010) Distinct Bifidobacterium strains drive different immune responses in vitro. Int J Food Microbiol 138, 157–165.
18Dong, H, Rowland, I, Tuohy, KM, et al. (2010) Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production. Clin Exp Immunol 161, 378–388.
19Hessle, C, Hanson, LA & Wold, AE (1999) Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin Exp Immunol 116, 276–282.
20Drago, L, Nicola, L, Iemoli, E, et al. (2010) Strain-dependent release of cytokines modulated by Lactobacillus salivarius human isolates in an in vitro model. BMC Res Notes 3, 44–48.
21Foligne, B, Nutten, S, Grangette, C, et al. (2007) Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol 13, 236–243.
22Mastrangeli, G, Corinti, S, Butteroni, C, et al. (2009) Effects of live and inactivated VSL#3 probiotic preparations in the modulation of in vitro and in vivo allergen-induced Th2 responses. Int Arch Allergy Immunol 150, 133–143.
23Flinterman, AE, Knol, EF, van Ieperen-Van Dijk, AG, et al. (2007) Probiotics have a different immunomodulatory potential in vitro versus ex vivo upon oral administration in children with food allergy. Int Arch Allergy Immunol 143, 237–244.
24Kekkonen, RA, Lummela, N, Karjalainen, H, et al. (2008) Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World J Gastroenterol 14, 2029–2036.
25Rea, IM, McNerlan, SE & Alexander, HD (1999) CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging. Exp Gerontol 34, 79–93.
26Meyer, AL, Micksche, M, Herbacek, I, et al. (2006) Daily intake of probiotic as well as conventional yogurt has a stimulating effect on cellular immunity in young healthy women. Ann Nutr Metab 50, 282–289.
27Ozkan, TB, Sahin, E, Erdemir, G, et al. (2007) Effect of Saccharomyces boulardii in children with acute gastroenteritis and its relationship to the immune response. J Int Med Res 35, 201–212.
28de Vrese, M, Winkler, P, Rautenberg, P, et al. (2005) Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr 24, 481–491.
29Garciapenarrubia, P, Koster, FT, Kelley, RO, et al. (1989) Antibacterial activity of human natural-killer cells. J Exp Med 169, 99–113.
30Olivares, M, Diaz-Ropero, MP, Sierra, S, et al. (2007) Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23, 254–260.
31Bunout, D, Barrera, G, Hirsch, S, et al. (2004) Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. J Parenter Enter Nutr 28, 348–354.
32Roller, M, Clune, Y, Collins, K, et al. (2007) Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. Br J Nutr 97, 676–684.
33Spanhaak, S, Havenaar, R & Schaafsma, G (1998) The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. Eur J Clin Nutr 52, 899–907.
34Cox, AJ, Pyne, DB, Saunders, PU, et al. (2010) Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br J Sports Med 44, 222–226.
35Ishikawa, H, Akedo, I, Otani, T, et al. (2005) Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer 116, 762–767.
36de Roock, S, van Elk, M, van Dijk, MEA, et al. (2010) Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin Exp Allergy 40, 103–110.
37Kalliomaki, M, Antoine, JM, Herz, U, et al. (2010) Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J Nutr 140, 713S–721S.
38Weaver, CT, Harrington, LE, Mangan, PR, et al. (2006) Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 24, 677–688.
39Singh, VK, Mehrotra, S & Agarwal, SS (1999) The paradigm of Th1 and Th2 cytokines – its relevance to autoimmunity and allergy. Immunol Res 20, 147–161.
40Borchers, AT, Selmi, C, Meyers, FJ, et al. (2009) Probiotics and immunity. J Gastroenterol 44, 26–46.
41Kekkonen, RA, Kajasto, E, Miettinen, M, et al. (2008) Probiotic Leuconostoc mesenteroides ssp cremoris and Streptococcus thermophilus induce IL-12 and IFN-gamma production. World J Gastroenterol 14, 1192–1203.
42Timmerman, HM, Niers, LEM, Ridwan, BU, et al. (2007) Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients. Clin Nutr 26, 450–459.
43Vissers, YM, Snel, J, Zuurendonk, PF, et al. (2010) Differential effects of Lactobacillus acidophilus and Lactobacillus plantarum strains on cytokine induction in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 59, 60–70.
44Miettinen, M, VuopioVarkila, J & Varkila, K (1996) Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect Immun 64, 5403–5405.
45Hessle, C, Andersson, B & Wold, AE (2000) Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect Immun 68, 3581–3586.
46Hart, AL, Lammers, K, Brigidi, P, et al. (2004) Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 53, 1602–1609.
47Lammers, KM, Brigidi, P, Vitali, B, et al. (2003) Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 38, 165–172.
48Niers, LEM, Timmerman, HM, Rijkers, GT, et al. (2005) Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy 35, 1481–1489.
49Ji, GE (2009) Probiotics in primary prevention of atopic dermatitis. In Food Factors for Health Promotion, pp. 117–128. Basel: Karger.
50Clancy, RL & Pang, G (2007) Probiotics – industry myth or a practical reality? J Am Coll Nutr 26, 691S–694S.
51Kaji, R, Kiyoshima-Shibata, J, Nagaoka, M, et al. (2010) Bacterial teichoic acids reverse predominant IL-12 production induced by certain Lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. J Immunol 184, 3505–3513.
52Ivory, K, Chambers, SJ, Pin, C, et al. (2008) Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis. Clin Exp Allergy 38, 1282–1289.
53Shima, T, Fukushima, K, Setoyama, H, et al. (2008) Differential effects of two probiotic strains with different bacteriological properties on intestinal gene expression, with special reference to indigenous bacteria. FEMS Immunol Med Microbiol 52, 69–77.
54Kobayashi, T, Kato, I, Nanno, M, et al. (2010) Oral administration of probiotic bacteria, Lactobacillus casei and Bifidobacterium breve, does not exacerbate neurological symptoms in experimental autoimmune encephalomyelitis. Immunopharmacol Immunotoxicol 32, 116–124.
55Matsumoto, S (2008) Anti-inflammatroy effects of probiotic Lactobacillus casei strain Shirota in chronic intestinal inflammatory disorders. Int J Probiotics Prebiotics 3, 149–152.
56Pena, JA & Versalovic, J (2003) Lactobacillus rhamnosus GG decreases TNF-alpha production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cell Microbiol 5, 277–285.
57Pessi, T, Sutas, Y, Hurme, H, et al. (2000) Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 30, 1804–1808.
58Isolauri, E, Arvola, T, Sutas, Y, et al. (2000) Probiotics in the management of atopic eczema. Clin Exp Allergy 30, 1604–1610.
59Kalliomaki, M, Salminen, S, Arvilommi, H, et al. (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357, 1076–1079.
60Viljanen, M, Savilahti, E, Haahtela, T, et al. (2005) Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 60, 494–500.
61Kukkonen, K, Kuitunen, M, Haahtela, T, et al. (2010) High intestinal IgA associates with reduced risk of IgE-associated allergic diseases. Pediatr Allergy Immunol 21, 67–73.
62de Jonge, JD, Ezendam, J, Knippels, LMJ, et al. (2008) Lactobacillus casei Shirota does not decrease the food allergic response to peanut extract in Brown Norway rats. Toxicology 249, 140–145.
63Kopp, MV, Hennemuth, I, Heinzmann, A, et al. (2008) Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 121, E850–E856.
64Rose, CE, Sung, SSJ & Fu, SM (2003) Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 10, 273–288.
65Steensberg, A, Fischer, CP, Keller, C, et al. (2003) IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 285, E433–E437.